位置:首页 > 蛋白库 > CUL4B_MOUSE
CUL4B_MOUSE
ID   CUL4B_MOUSE             Reviewed;         970 AA.
AC   A2A432; Q3TU30; Q8BSL3; Q8CHD6; Q91YZ7; Q99KS9; Q9CZM5;
DT   15-JUN-2010, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 1.
DT   03-AUG-2022, entry version 119.
DE   RecName: Full=Cullin-4B {ECO:0000305};
DE            Short=CUL-4B {ECO:0000303|PubMed:16052071};
GN   Name=Cul4b {ECO:0000303|PubMed:16052071, ECO:0000312|MGI:MGI:1919834};
GN   Synonyms=Kiaa0695 {ECO:0000303|PubMed:12465718};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000312|EMBL:AAP84984.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=129/Sv {ECO:0000312|EMBL:AAP84984.1};
RC   TISSUE=Embryonic carcinoma {ECO:0000312|EMBL:AAP84984.1};
RX   PubMed=16052071; DOI=10.1007/bf02703670;
RA   Tripathi R., Sastry K.S., Kota S.K., Srinivas U.K.;
RT   "Cloning and characterization of mouse cullin4B/E3 ubiquitin ligase.";
RL   J. Biosci. 30:329-337(2005).
RN   [2] {ECO:0000312|EMBL:BAC27992.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAC27992.1};
RC   TISSUE=Embryonic head {ECO:0000312|EMBL:BAE36141.1},
RC   Head {ECO:0000312|EMBL:BAE36141.1}, and
RC   Wolffian duct {ECO:0000312|EMBL:BAC27992.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3] {ECO:0000312|EMBL:CAM17145.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4] {ECO:0000312|EMBL:EDL29019.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000312|EMBL:AAH04026.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Czech II {ECO:0000312|EMBL:AAH04026.1}, and
RC   FVB/N {ECO:0000312|EMBL:AAH10347.1};
RC   TISSUE=Mammary tumor {ECO:0000312|EMBL:AAH04026.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6] {ECO:0000312|EMBL:BAC41443.3}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 204-970 (ISOFORM 2).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAC41443.3};
RX   PubMed=12465718; DOI=10.1093/dnares/9.5.179;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Hara Y., Nagase T., Ohara O.,
RA   Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: I.
RT   The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 9:179-188(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-15; SER-17; THR-106; SER-110
RP   AND THR-202, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, Pancreas, Spleen,
RC   and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-
CC       protein ligase complexes which mediate the ubiquitination and
CC       subsequent proteasomal degradation of target proteins. The functional
CC       specificity of the E3 ubiquitin-protein ligase complex depends on the
CC       variable substrate recognition subunit. CUL4B may act within the
CC       complex as a scaffold protein, contributing to catalysis through
CC       positioning of the substrate and the ubiquitin-conjugating enzyme.
CC       Plays a role as part of the E3 ubiquitin-protein ligase complex in
CC       polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in
CC       response to radiation-induced DNA damage. Targeted to UV damaged
CC       chromatin by DDB2 and may be important for DNA repair and DNA
CC       replication. A number of DCX complexes (containing either TRPC4AP or
CC       DCAF12 as substrate-recognition component) are part of the DesCEND
CC       (destruction via C-end degrons) pathway, which recognizes a C-degron
CC       located at the extreme C terminus of target proteins, leading to their
CC       ubiquitination and degradation. The DCX(AMBRA1) complex is a master
CC       regulator of the transition from G1 to S cell phase by mediating
CC       ubiquitination of phosphorylated cyclin-D (CCND1, CCND2 and CCND3). The
CC       DCX(AMBRA1) complex also acts as a regulator of Cul5-RING (CRL5) E3
CC       ubiquitin-protein ligase complexes by mediating ubiquitination and
CC       degradation of Elongin-C (ELOC) component of CRL5 complexes. Required
CC       for ubiquitination of cyclin E (CCNE1 or CCNE2), and consequently,
CC       normal G1 cell cycle progression. Regulates the mammalian target-of-
CC       rapamycin (mTOR) pathway involved in control of cell growth, size and
CC       metabolism. Specific CUL4B regulation of the mTORC1-mediated pathway is
CC       dependent upon 26S proteasome function and requires interaction between
CC       CUL4B and MLST8. With CUL4A, contributes to ribosome biogenesis.
CC       {ECO:0000250|UniProtKB:Q13620}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q13620}.
CC   -!- SUBUNIT: Component of multiple DCX (DDB1-CUL4-X-box) E3 ubiquitin-
CC       protein ligase complexes that seem to be formed of DDB1, CUL4A or
CC       CUL4B, RBX1 and a variable substrate recognition component which seems
CC       to belong to a protein family described as DCAF (Ddb1- and Cul4-
CC       associated factor) or CDW (CUL4-DDB1-associated WD40-repeat) proteins.
CC       Component of the DCX(DTL) complex with the putative substrate
CC       recognition component DTL. Component of the DCX(DDB2) complex with the
CC       putative substrate recognition component DDB2. Component of DCX
CC       complexes part of the DesCEND (destruction via C-end degrons) pathway,
CC       which contain either TRPC4AP or DCAF12 as substrate-recognition
CC       component. Component of the DCX(AMBRA1) complex with the substrate
CC       recognition component AMBRA1. Part of a complex with RBX1 and
CC       TIP120A/CAND1. Interacts with RBX1, GRWD1, MLST8, SMU1, TLE2, TLE3,
CC       DCAF1, DDA1, DCAF6, DCAF17, DDB2, DCAF8, TIP120A/CAND1 and TMEM113.
CC       Interacts with cyclin E (CCNE1 or CCNE2) and with importins alpha-1
CC       (KPNA2), alpha-3 (KPNA4), alpha-5 (KPNA1) and beta-1 (KPNB1). May
CC       interact with WDR26, WDR51B, SNRNP40, WDR61, WDR76 and WDR5. Interacts
CC       (unneddylated form) with DCUN1D1, DCUN1D2, DCUN1D3, DCUN1D4 and
CC       DCUN1D5; these interactions promote the cullin neddylation.
CC       {ECO:0000250|UniProtKB:Q13620}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13620}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16052071,
CC       ECO:0000269|PubMed:16141072, ECO:0000269|PubMed:19468303};
CC         IsoId=A2A432-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:12465718};
CC         IsoId=A2A432-2; Sequence=VSP_039242;
CC   -!- PTM: Neddylated. Deneddylated via its interaction with the COP9
CC       signalosome (CSN) complex (By similarity).
CC       {ECO:0000250|UniProtKB:Q13620}.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04026.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH10347.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC41443.3; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY330868; AAP84984.1; -; mRNA.
DR   EMBL; AK012410; BAB28222.2; -; mRNA.
DR   EMBL; AK032701; BAC27992.1; -; mRNA.
DR   EMBL; AK160998; BAE36141.1; -; mRNA.
DR   EMBL; AL513356; CAM17145.1; -; Genomic_DNA.
DR   EMBL; CH466570; EDL29019.1; -; Genomic_DNA.
DR   EMBL; BC004026; AAH04026.1; ALT_INIT; mRNA.
DR   EMBL; BC010347; AAH10347.1; ALT_INIT; mRNA.
DR   EMBL; AB093259; BAC41443.3; ALT_INIT; Transcribed_RNA.
DR   CCDS; CCDS40948.1; -. [A2A432-1]
DR   RefSeq; NP_001103612.1; NM_001110142.1. [A2A432-1]
DR   RefSeq; NP_082564.3; NM_028288.5. [A2A432-1]
DR   AlphaFoldDB; A2A432; -.
DR   SMR; A2A432; -.
DR   BioGRID; 215452; 63.
DR   ComplexPortal; CPX-651; CRL4-DDB2 E3 ubiquitin ligase complex, CUL4B variant.
DR   IntAct; A2A432; 2.
DR   STRING; 10090.ENSMUSP00000059276; -.
DR   iPTMnet; A2A432; -.
DR   PhosphoSitePlus; A2A432; -.
DR   EPD; A2A432; -.
DR   jPOST; A2A432; -.
DR   MaxQB; A2A432; -.
DR   PaxDb; A2A432; -.
DR   PeptideAtlas; A2A432; -.
DR   PRIDE; A2A432; -.
DR   ProteomicsDB; 285230; -. [A2A432-1]
DR   ProteomicsDB; 285231; -. [A2A432-2]
DR   Antibodypedia; 531; 441 antibodies from 35 providers.
DR   DNASU; 72584; -.
DR   Ensembl; ENSMUST00000050083; ENSMUSP00000059276; ENSMUSG00000031095. [A2A432-1]
DR   Ensembl; ENSMUST00000115118; ENSMUSP00000110771; ENSMUSG00000031095. [A2A432-1]
DR   GeneID; 72584; -.
DR   KEGG; mmu:72584; -.
DR   UCSC; uc009taa.2; mouse. [A2A432-1]
DR   CTD; 8450; -.
DR   MGI; MGI:1919834; Cul4b.
DR   VEuPathDB; HostDB:ENSMUSG00000031095; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   GeneTree; ENSGT00940000155339; -.
DR   InParanoid; A2A432; -.
DR   OMA; WPTYPVM; -.
DR   PhylomeDB; A2A432; -.
DR   TreeFam; TF101153; -.
DR   Reactome; R-MMU-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-MMU-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-MMU-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-MMU-5696400; Dual Incision in GG-NER.
DR   Reactome; R-MMU-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-MMU-6782135; Dual incision in TC-NER.
DR   Reactome; R-MMU-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 72584; 9 hits in 112 CRISPR screens.
DR   ChiTaRS; Cul4b; mouse.
DR   PRO; PR:A2A432; -.
DR   Proteomes; UP000000589; Chromosome X.
DR   RNAct; A2A432; protein.
DR   Bgee; ENSMUSG00000031095; Expressed in secondary oocyte and 237 other tissues.
DR   ExpressionAtlas; A2A432; baseline and differential.
DR   Genevisible; A2A432; MM.
DR   GO; GO:0080008; C:Cul4-RING E3 ubiquitin ligase complex; ISO:MGI.
DR   GO; GO:0031464; C:Cul4A-RING E3 ubiquitin ligase complex; IC:ComplexPortal.
DR   GO; GO:0031465; C:Cul4B-RING E3 ubiquitin ligase complex; ISS:UniProtKB.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0003684; F:damaged DNA binding; ISO:MGI.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0048708; P:astrocyte differentiation; IMP:MGI.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IBA:GO_Central.
DR   GO; GO:0034644; P:cellular response to UV; IC:ComplexPortal.
DR   GO; GO:0010467; P:gene expression; IMP:MGI.
DR   GO; GO:0035518; P:histone H2A monoubiquitination; ISO:MGI.
DR   GO; GO:0031175; P:neuron projection development; ISO:MGI.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:MGI.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IMP:MGI.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; ISO:MGI.
DR   GO; GO:0016567; P:protein ubiquitination; ISO:MGI.
DR   GO; GO:0042254; P:ribosome biogenesis; IMP:UniProtKB.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0070914; P:UV-damage excision repair; ISO:MGI.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR033044; CUL4B.
DR   InterPro; IPR045093; Cullin.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11932; PTHR11932; 1.
DR   PANTHER; PTHR11932:SF66; PTHR11932:SF66; 1.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; DNA damage; DNA repair; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN           1..970
FT                   /note="Cullin-4B"
FT                   /id="PRO_0000394426"
FT   REGION          1..157
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          189..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           112..115
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q13620"
FT   COMPBIAS        1..35
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        36..58
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        75..157
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         15
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         106
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         154
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13619"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13620"
FT   MOD_RES         202
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13620"
FT   CROSSLNK        247
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13619"
FT   CROSSLNK        916
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in NEDD8)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13620"
FT   VAR_SEQ         693..721
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12465718"
FT                   /id="VSP_039242"
FT   CONFLICT        56
FT                   /note="P -> A (in Ref. 2; BAB28222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209
FT                   /note="Q -> E (in Ref. 6; BAC41443)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        593
FT                   /note="K -> E (in Ref. 2; BAB28222)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        933
FT                   /note="Q -> R (in Ref. 1; AAP84984 and 2; BAC27992)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        966
FT                   /note="Y -> S (in Ref. 6; BAC41443)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   970 AA;  110699 MW;  87D518B268A21849 CRC64;
     MSRSTRSKER RENDTDSEDN SSETSNQERR RCRQGPPRPP YPPLLPPVFP PPTPPPQVRR
     TRGLQDLGAM KSVCPGTSGF SSPNPSAASA AAQEVRSATD GNTSTTPPTS AKKRKLNSSS
     SSSNSSNERE DFDSTSSSST PPQPRDSASP STSSFCLGVP VATSSHVPIQ KKLRFEDTLE
     FVGIDTKMAE ESSSSSSSSS PTAATSQQQQ QQQLKTKSIL ISSVASVHHA NGLAKSSTAV
     SSFANSKPGS AKKLVIKNFK DKPKLPENYT DETWQKLKEA VEAIQNSTSI KYNLEELYQA
     VENLCSHKIS ANLYKQLRQI CEDHIKAQIH QFREDSLDSV LFLKKIDRCW QNHCRQMIMI
     RSIFLFLDRT YVLQNSMLPS IWDMGLELFR AHIISDQKVQ TKTIDGILLL IERERNGEAI
     DRSLLRSLLS MLSDLQIYQD SFEQQFLQET NRLYAAEGQK LMQEREVPEY LHHVNKRLEE
     EADRLITYLD QTTQKSLIAS VEKQLLGEHL TAILQKGLNS LLDENRIQDL SLLYQLFSRV
     RGGVQVLLQQ WIEYIKAFGS TIVINPEKDK TMVQELLDFK DKVDHIIDTC FLKNEKFINA
     MKEAFETFIN KRPNKPAELI AKYVDSKLRA GNKEATDEEL EKMLDKIMII FRFIYGKDVF
     EAFYKKDLAK RLLVGKSASV DAEKSMLSKL KHECGAAFTS KLEGMFKDME LSKDIMIQFK
     QYMQNQNVPG NIELTVNILT MGYWPTYVPM EVHLPPEMVK LQEIFKTFYL GKHSGRKLQW
     QSTLGHCVLK AEFKEGKKEL QVSLFQTMVL LMFNEGEEFS LEEIKHATGI EDGELRRTLQ
     SLACGKARVL AKNPKGKDIE DGDKFICNDD FKHKLFRIKI NQIQMKETVE EQASTTERVF
     QDRQYQIDAA IVRIMKMRKT LSHNLLVSEV YNQLKFPVKP ADLKKRIESL IDRDYMERDK
     ENPNQYNYIA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025